Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
In some embodiments, systems and methods can include a wearable device with an electrically conductive skin interface that excites the underlying nerves from a transcutaneous surface stimulator. The device may be sized for a range of user sizes with stimulation electrodes positioned to target the appropriate nerves, such as the saphenous and/or tibial nerves. The stimulation could include burst stimulation, and involve receiving an input relating to autonomic nervous system activity of the patient, and modifying at least one brain or spinal cord autonomic feedback loop relating to bladder function based on the input to balance parasympathetic and sympathetic nervous system activity of the patient.
1. A method of treating urinary symptoms in a patient with dual transcutaneous stimulation of a first afferent lower extremity nerve and a second afferent lower extremity nerve, comprising:
positioning a first peripheral nerve effector on the patient's skin to stimulate the first afferent lower extremity nerve of the patient;
positioning a second peripheral nerve effector on the patient's skin to stimulate the second afferent lower extremity nerve of the patient;
delivering a first electrical nerve stimulation signal transcutaneously to the first afferent lower extremity nerve through the first peripheral nerve effector;
delivering a second electrical nerve stimulation signal transcutaneously to the second afferent lower extremity nerve through the second peripheral nerve effector;
receiving an input relating to autonomic nervous system activity of the patient; and
modifying at least one brain or spinal cord autonomic feedback loop relating to bladder function based on the input to balance parasympathetic and sympathetic nervous system activity of the patient,
wherein the method does not utilize any implantable components, and only involves transcutaneous stimulation,
wherein the first electrical stimulation signal and the second electrical stimulation signal comprise burst electrical stimulation signals, wherein the burst electrical stimulation signals induce neural plasticity.
2. The method of claim 1 , wherein the burst stimulation signals comprises alpha, delta, or theta burst stimulation.
3. The method of claim 1 , wherein the burst stimulation signals comprises theta burst stimulation.
4. The method of claim 1 , wherein the burst stimulation signals comprise continuous, intermittent, or intermediate theta burst stimulation.
5. The method of claim 1 , wherein the first electrical stimulation comprises a stimulation parameter modulated within a range from a first lower predetermined value to a second higher predetermined value, wherein the stimulation parameter is selected from the group consisting of pulse width, frequency, and amplitude.
6. The method of claim 1 , wherein the first electrical stimulation comprises a randomized stimulation parameter selected from the group consisting of: pulse width, frequency, and amplitude.
7. The method of claim 1 , wherein the first electrical stimulation signal is stimulatory to the first afferent lower extremity peripheral nerve.
8. The method of claim 1 , wherein the first electrical stimulation signal is inhibitory to the first afferent lower extremity peripheral nerve.
9. The method of claim 1 , wherein the first electrical stimulation signal is stimulatory to the first afferent lower extremity peripheral nerve, and the second electrical stimulatory signal is inhibitory to the second afferent lower extremity peripheral nerve.
10. The method of claim 1 , further comprising delivering a priming electrical nerve stimulation signal prior to the first electrical stimulation signal, wherein the priming electrical nerve stimulation signal is a non-theta burst stimulation signal.
11. The method of claim 1 , further comprising alternating the first electrical nerve stimulation signal to the first afferent lower extremity peripheral nerve and the second peripheral nerve signal to the second afferent lower extremity peripheral nerve.
12. The method of claim 1 , wherein the first afferent lower extremity peripheral nerve is one of the saphenous nerve and a tibial nerve, and the method treats overactive bladder, nocturia, or stress incontinence of the user.
13. The method of claim 1 , wherein the first afferent lower extremity peripheral nerve and the second afferent lower extremity peripheral nerve is selected from the group consisting of: a saphenous nerve and a tibial nerve, and the method reduces overactive bladder, nocturia, or stress incontinence of the user.
14. A wearable device for dual transcutaneous stimulation of a first afferent lower extremity nerve and a second afferent lower extremity nerve and for treating urinary symptoms in a patient, the device comprising:
a controller;
a first peripheral nerve effector, comprising at least one stimulation electrode configured to be positioned to transcutaneously modulate the saphenous nerve;
a second peripheral nerve effector, comprising at least one stimulation electrode configured to be positioned to transcutaneously modulate the tibial nerve; and
at least one biomedical sensor or data input source configured to provide feedback information;
wherein the controller comprises a processor and a memory for receiving the feedback information from the sensor that, when executed by the processor, cause the device to:
adjust one or more parameters of a first electrical stimulus and a second electrical stimulus based at least in part on the feedback information; and
deliver the first electrical stimulus to the first afferent lower extremity nerve through the first peripheral nerve effector and deliver the second electrical stimulus to the second afferent lower extremity nerve through the second peripheral nerve effector to reduce urinary symptoms by modifying a brain or spinal cord autonomic feedback loop relating to bladder function and balancing sympathetic nerve and parasympathetic nerve activity,
wherein the device is not configured for implantation within the patient,
wherein the first electrical stimulus and the second electrical stimulus both comprise burst stimulation.
15. The wearable device of claim 14 , wherein the burst stimulation comprises theta burst stimulation.
16. The wearable device of claim 14 , wherein the first peripheral nerve effector is not physically connected to the second peripheral nerve effector.
17. A method of treating urinary symptoms in a patient with transcutaneous stimulation of an afferent lower extremity nerve, comprising:
positioning a first peripheral nerve effector on the patient's skin to stimulate the afferent lower extremity nerve of the patient;
delivering a first electrical nerve stimulation signal transcutaneously to the afferent lower extremity nerve through the first peripheral nerve effector;
receiving an input relating to autonomic nervous system activity of the patient; and
modifying at least one brain or spinal cord autonomic feedback loop relating to bladder function based on the input to balance parasympathetic and sympathetic nervous system activity of the patient,
wherein the method does not utilize any implantable components, and only involves transcutaneous stimulation,
wherein the first electrical stimulation signal comprises burst electrical stimulation signals, wherein the burst electrical stimulation signals induce neural plasticity.
18. The method of claim 17 , wherein the burst stimulation signals comprises alpha, delta, or theta burst stimulation.
19. The method of claim 17 , wherein the burst stimulation signals comprises theta burst stimulation.